297 related articles for article (PubMed ID: 30155493)
1. Description of CD8
Vieyra-Lobato MR; Vela-Ojeda J; Montiel-Cervantes L; López-Santiago R; Moreno-Lafont MC
J Immunol Res; 2018; 2018():3758713. PubMed ID: 30155493
[TBL] [Abstract][Full Text] [Related]
2. TGF-β-Induced CD8
Zhong H; Liu Y; Xu Z; Liang P; Yang H; Zhang X; Zhao J; Chen J; Fu S; Tang Y; Lv J; Wang J; Olsen N; Xu A; Zheng SG
Front Immunol; 2018; 9():35. PubMed ID: 29441062
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of CD4+CD25+ and CD8+ regulatory T cells--review].
Ou Y; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1137-40. PubMed ID: 16403299
[TBL] [Abstract][Full Text] [Related]
4. CD8+CD103+ iTregs Inhibit Chronic Graft-versus-Host Disease with Lupus Nephritis by the Increased Expression of CD39.
Zhang X; Ouyang X; Xu Z; Chen J; Huang Q; Liu Y; Xu T; Wang J; Olsen N; Xu A; Zheng SG
Mol Ther; 2019 Nov; 27(11):1963-1973. PubMed ID: 31402273
[TBL] [Abstract][Full Text] [Related]
5. Human CD39
Gu J; Ni X; Pan X; Lu H; Lu Y; Zhao J; Guo Zheng S; Hippen KL; Wang X; Lu L
Cell Mol Immunol; 2017 Jun; 14(6):521-528. PubMed ID: 27374793
[TBL] [Abstract][Full Text] [Related]
6. Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.
Fenoglio D; Ferrera F; Fravega M; Balestra P; Battaglia F; Proietti M; Andrei C; Olive D; Antonio LC; Indiveri F; Filaci G
Hum Immunol; 2008 Nov; 69(11):745-50. PubMed ID: 18832002
[TBL] [Abstract][Full Text] [Related]
7. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.
Åkesson K; Tompa A; Rydén A; Faresjö M
Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756
[TBL] [Abstract][Full Text] [Related]
8. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
[TBL] [Abstract][Full Text] [Related]
11. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
[TBL] [Abstract][Full Text] [Related]
12. MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Wu L; Li N; Zhang M; Xue SL; Cassady K; Lin Q; Riggs AD; Zeng D
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15994-9. PubMed ID: 26647186
[TBL] [Abstract][Full Text] [Related]
13. iTreg induced from CD39(+) naive T cells demonstrate enhanced proliferate and suppressive ability.
Lu Y; Wang X; Gu J; Lu H; Zhang F; Li X; Qian X; Wang X; Lu L
Int Immunopharmacol; 2015 Oct; 28(2):925-30. PubMed ID: 25864618
[TBL] [Abstract][Full Text] [Related]
14. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
15. Identification of tonsillar CD4
Sumitomo S; Nakachi S; Okamura T; Tsuchida Y; Kato R; Shoda H; Furukawa A; Kitahara N; Kondo K; Yamasoba T; Yamamoto K; Fujio K
J Autoimmun; 2017 Jan; 76():75-84. PubMed ID: 27653378
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 control over Foxp3+ regulatory T cell function.
Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T; Miyara M; Fehervari Z; Nomura T; Sakaguchi S
Science; 2008 Oct; 322(5899):271-5. PubMed ID: 18845758
[TBL] [Abstract][Full Text] [Related]
17. Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation.
Ligocki AJ; Niederkorn JY
Transplantation; 2015 Aug; 99(8):1553-9. PubMed ID: 26193065
[TBL] [Abstract][Full Text] [Related]
18. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.
Zhang S; Ke X; Zeng S; Wu M; Lou J; Wu L; Huang P; Huang L; Wang F; Pan S
Cell Mol Immunol; 2015 Sep; 12(5):580-91. PubMed ID: 26166762
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
[TBL] [Abstract][Full Text] [Related]
20. Harnessing CD8
Ceeraz S; Thompson CR; Beatson R; Choy EH
Cells; 2021 Nov; 10(11):. PubMed ID: 34831195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
